The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Oncology Institute Inc shares valued at $82,097 were sold by Hively Brad on Aug 19 ’25. At $4.06 per share, Hively Brad sold 20,221 shares. The insider’s holdings dropped to 622,980 shares worth approximately $2.01 million following the completion of this transaction.
Also, M33 Growth I L.P. sold 673,676 shares, netting a total of over 2,054,712 in proceeds. Following the sale of shares at $3.05 each, the insider now holds 13,950,557 shares.
Before that, M33 Growth I L.P. had sold 76,324 shares from its account. In a trade valued at $232,788, the Director traded Oncology Institute Inc shares for $3.05 each. Upon closing the transaction, the insider’s holdings decreased to 76,324 shares, worth approximately $4.11 million.
As published in their initiating research note from Noble Capital Markets on July 23, 2025, Oncology Institute Inc [TOI] has been an Outperform and the price target has been revised to $8. Analysts at B. Riley Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in mid July. As of May 15, 2025, BTIG Research has initiated its “Buy” rating for TOI.
Analyzing TOI Stock Performance
On last trading session, Oncology Institute Inc [NASDAQ: TOI] plunged -0.62% to $3.23. The stock’s lowest price that day was $3.21, but it reached a high of $3.3699 in the same session. During the last five days, there has been a drop of approximately -7.45%. Over the course of the year, Oncology Institute Inc shares have jumped approximately 746.55%. Shares of the company reached a 52-week high of $4.50 on 08/07/25 and a 52-week low of $0.25 on 01/10/25.
Support And Resistance Levels for Oncology Institute Inc (TOI)
According to the 24-hour chart, there is a support level at 3.17, which, if violated, would cause prices to drop to 3.11. In the upper region, resistance lies at 3.33. The next price resistance is at 3.43. RSI (Relative Strength Index) is 38.57 on the 14-day chart, showing neutral technical sentiment.
Is Oncology Institute Inc subject to short interest?
Stocks of Oncology Institute Inc saw a sharp steep in short interest on 2025-08-15 dropping by -0.9 million shares to 6.25 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 7.15 million shares. A decline of -14.36% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.93 of the overall float, the days-to-cover ratio (short ratio) decline to 2.93.
Which companies own the most shares of Oncology Institute Inc (TOI)?
In terms of Oncology Institute Inc share price expectations, FactSet research, analysts set an average price target of 8 in the next 12 months, up nearly 146.15% from the previous closing price of $3.25. Analysts anticipate Oncology Institute Inc stock to reach 10 by 2025, with the lowest price target being 6. In spite of this, 2 analysts ranked Oncology Institute Inc stock as Buy at the end of 2025. On September 14, 2022, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $7.
